A citation-based method for searching scientific literature

Jisoo Park, Yuwen Li, Seon-Hwan Kim, Gyeyeong Kong, Robin Shrestha, Quangdon Tran, Janghee Hong, Gang Min Hur, Brian A Hemmings, Bon Seok Koo, Jongsun Park. Life Sci 2013
Times Cited: 5







List of co-cited articles
14 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Small-molecule inhibitors of PDK1.
Christian Peifer, Dario R Alessi. ChemMedChem 2008
94
60

Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1.
Ayaz Najafov, Eeva M Sommer, Jeffrey M Axten, M Phillip Deyoung, Dario R Alessi. Biochem J 2011
98
40



The nuts and bolts of AGC protein kinases.
Laura R Pearce, David Komander, Dario R Alessi. Nat Rev Mol Cell Biol 2010
858
40

Biorefineries.
Jong-Moon Park, Akihiko Kondo, Jo-Shu Chang, C Perry Chou, Pierre Monsan. Bioresour Technol 2013
45
40

3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase.
D R Alessi, M Deak, A Casamayor, F B Caudwell, N Morrice, D G Norman, P Gaffney, C B Reese, C N MacDougall, D Harbison,[...]. Curr Biol 1997
580
40

Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B.
L Stephens, K Anderson, D Stokoe, H Erdjument-Bromage, G F Painter, A B Holmes, P R Gaffney, C B Reese, F McCormick, P Tempst,[...]. Science 1998
882
40

PDK1, the master regulator of AGC kinase signal transduction.
Alfonso Mora, David Komander, Daan M F van Aalten, Dario R Alessi. Semin Cell Dev Biol 2004
581
40

AGC protein kinases: from structural mechanism of regulation to allosteric drug development for the treatment of human diseases.
José M Arencibia, Daniel Pastor-Flores, Angelika F Bauer, Jörg O Schulze, Ricardo M Biondi. Biochim Biophys Acta 2013
93
40

PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2.
A Balendran, A Casamayor, M Deak, A Paterson, P Gaffney, R Currie, C P Downes, D R Alessi. Curr Biol 1999
367
40

Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA.
R M Biondi, P C Cheung, A Casamayor, M Deak, R A Currie, D R Alessi. EMBO J 2000
217
40

In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation.
Barry J Collins, Maria Deak, J Simon C Arthur, Laura J Armit, Dario R Alessi. EMBO J 2003
151
40

Regulation of matrix metalloproteinase activity in health and disease.
Elin Hadler-Olsen, Bodil Fadnes, Ingebrigt Sylte, Lars Uhlin-Hansen, Jan-Olof Winberg. FEBS J 2011
250
20

ExPASy: SIB bioinformatics resource portal.
Panu Artimo, Manohar Jonnalagedda, Konstantin Arnold, Delphine Baratin, Gabor Csardi, Edouard de Castro, Séverine Duvaud, Volker Flegel, Arnaud Fortier, Elisabeth Gasteiger,[...]. Nucleic Acids Res 2012
907
20

Alpha 1-adrenoceptors: function and phosphorylation.
J A García-Sáinz, J Vázquez-Prado, L del Carmen Medina. Eur J Pharmacol 2000
103
20




The Protein Model Portal--a comprehensive resource for protein structure and model information.
Juergen Haas, Steven Roth, Konstantin Arnold, Florian Kiefer, Tobias Schmidt, Lorenza Bordoli, Torsten Schwede. Database (Oxford) 2013
184
20

Triggering of a novel intrinsic apoptosis pathway by the kinase inhibitor staurosporine: activation of caspase-9 in the absence of Apaf-1.
Joachim Manns, Merle Daubrawa, Stefan Driessen, Florian Paasch, Nadine Hoffmann, Antje Löffler, Kirsten Lauber, Alexandra Dieterle, Sebastian Alers, Thomas Iftner,[...]. FASEB J 2011
60
20

The selectivity of protein kinase inhibitors: a further update.
Jenny Bain, Lorna Plater, Matt Elliott, Natalia Shpiro, C James Hastie, Hilary McLauchlan, Iva Klevernic, J Simon C Arthur, Dario R Alessi, Philip Cohen. Biochem J 2007
20

From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors.
Jiuxiang Zhu, Jui-Wen Huang, Ping-Hui Tseng, Ya-Ting Yang, Joseph Fowble, Chung-Wai Shiau, Yeng-Jeng Shaw, Samuel K Kulp, Ching-Shih Chen. Cancer Res 2004
213
20

Regulation of protein kinase C zeta by PI 3-kinase and PDK-1.
M M Chou, W Hou, J Johnson, L K Graham, M H Lee, C S Chen, A C Newton, B S Schaffhausen, A Toker. Curr Biol 1998
530
20


The discovery of receptor tyrosine kinases: targets for cancer therapy.
Andreas Gschwind, Oliver M Fischer, Axel Ullrich. Nat Rev Cancer 2004
817
20


Distinct phospholipase C-β isozymes mediate lysophosphatidic acid receptor 1 effects on intestinal epithelial homeostasis and wound closure.
Sei-Jung Lee, Giovanna Leoni, Philipp-Alexander Neumann, Jerold Chun, Asma Nusrat, C Chris Yun. Mol Cell Biol 2013
34
20

Receptor tyrosine kinases: mechanisms of activation and signaling.
Stevan R Hubbard, W Todd Miller. Curr Opin Cell Biol 2007
271
20


OSU-03012 in the treatment of glioblastoma.
James A McCubrey, Michelle M Lahair, Richard A Franklin. Mol Pharmacol 2006
15
20

Protein kinase C pharmacology: refining the toolbox.
Alyssa X Wu-Zhang, Alexandra C Newton. Biochem J 2013
127
20

Caspase-cleaved arrestin-2 and BID cooperatively facilitate cytochrome C release and cell death.
S Kook, X Zhan, W M Cleghorn, J L Benovic, V V Gurevich, E V Gurevich. Cell Death Differ 2014
33
20

Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition.
David Komander, Gursant S Kular, Jennifer Bain, Matthew Elliott, Dario R Alessi, Daan M F Van Aalten. Biochem J 2003
96
20

Dissecting how receptor tyrosine kinases modulate G protein-coupled receptor function.
J Adolfo García-Sáinz, M Teresa Romero-Ávila, Luz del Carmen Medina. Eur J Pharmacol 2010
17
20



PI3K signalling: the path to discovery and understanding.
Bart Vanhaesebroeck, Len Stephens, Phillip Hawkins. Nat Rev Mol Cell Biol 2012
565
20

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
Jennifer Vandooren, Philippe E Van den Steen, Ghislain Opdenakker. Crit Rev Biochem Mol Biol 2013
428
20

The emerging mechanisms of isoform-specific PI3K signalling.
Bart Vanhaesebroeck, Julie Guillermet-Guibert, Mariona Graupera, Benoit Bilanges. Nat Rev Mol Cell Biol 2010
20



G protein-coupled receptor cross-talk: pivotal roles of protein phosphorylation and protein-protein interactions.
José Vázquez-Prado, Patricia Casas-González, J Adolfo García-Sáinz. Cell Signal 2003
74
20

Oncogenic kinase signalling.
P Blume-Jensen, T Hunter. Nature 2001
20

Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.
D R Alessi, S R James, C P Downes, A B Holmes, P R Gaffney, C B Reese, P Cohen. Curr Biol 1997
20

Roles of phosphoinositide-dependent kinase-1 in α1B-adrenoceptor phosphorylation and desensitization.
Rocío Alcántara Hernández, J Adolfo García-Sáinz. Eur J Pharmacol 2012
2
50

Protein kinase C: poised to signal.
Alexandra C Newton. Am J Physiol Endocrinol Metab 2010
360
20

Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass.
Isabelle Gennero, Sara Laurencin-Dalicieux, Françoise Conte-Auriol, Fabienne Briand-Mésange, Danielle Laurencin, Jackie Rue, Nicolas Beton, Nicole Malet, Marianne Mus, Akira Tokumura,[...]. Bone 2011
47
20

Linkage of G protein-coupled receptors to the MAPK signaling pathway through PI 3-kinase gamma.
M Lopez-Ilasaca, P Crespo, P G Pellici, J S Gutkind, R Wetzker. Science 1997
606
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.